The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma von Vo, Josh N., Wu, Yi-Mi, Mishler, Jeanmarie, Hall, Sarah, Mannan, Rahul, Wang, Lisha, Ning, Yu, Zhou, Jin, Hopkins, Alexander C., Estill, James C., Chan, Wallace K. B., Yesil, Jennifer, Cao, Xuhong, Rao, Arvind, Tsodikov, Alexander, Talpaz, Moshe, Cole, Craig E., Ye, Jing C., Bergsagel, P. Leif, Auclair, Daniel, Cho, Hearn Jay, Robinson, Dan R., Chinnaiyan, Arul M.

Volltext

Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma von Wiernik, Peter H, Lossos, Izidore S, Tuscano, Joseph M, Justice, Glen, Vose, Julie M, Cole, Craig E, Lam, Wendy, McBride, Kyle, Wride, Kenton, Pietronigro, Dennis, Takeshita, Kenichi, Ervin-Haynes, Annette, Zeldis, Jerome B, Habermann, Thomas M

Volltext

Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel von Banerjee, Rahul, Biru, Yelak, Cole, Craig E., Faiman, Beth, Midha, Shonali, Ailawadhi, Sikander

Volltext

Multiple Myeloma for the Primary Care Provider: A Practical Review to Promote Earlier Diagnosis Among Diverse Populations von Mikhael, Joseph, Bhutani, Manisha, Cole, Craig E.

Volltext

Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma von Jakubowiak, Andrzej J., Jasielec, Jagoda K., Rosenbaum, Cara A., Cole, Craig E., Chari, Ajai, Mikhael, Joseph, Nam, Jennifer, McIver, Amanda, Severson, Erica, Stephens, Leonor A., Tinari, Kathryn, Rosebeck, Shaun, Zimmerman, Todd M., Hycner, Tyler, Turowski, Agata, Karrison, Theodore, Zonder, Jeffrey A.

Volltext

Essential Role of Caveolae in Interleukin-6- and Insulin-like Growth Factor I-triggered Akt-1-mediated Survival of Multiple Myeloma Cells von Podar, Klaus, Tai, Yu-Tzu, Cole, Craig E, Hideshima, Teru, Sattler, Martin, Hamblin, Angela, Mitsiades, Nicholas, Schlossman, Robert L, Davies, Faith E, Morgan, Gareth J, Munshi, Nikhil C, Chauhan, Dharminder, Anderson, Kenneth C

Volltext

Creating Equitable and Inclusive Clinical Trials for Multiple Myeloma von Hartley-Brown, Monique, Cole, Craig E, Price, Pamela, Andreini, Michael, Mulligan, George, Young, Anne Quinn, Cho, Hearn Jay

Volltext

A Typical Presentation of an Atypical Condition: Hepatic Angiosarcoma With Peritoneal Bleed von Afzal, Soha, Patel, Chintan, Kagathur, Santosh, Cole, Craig E

Volltext

Non-Toxicological Role of Aryl Hydrocarbon Receptor in Obesity-Associated Multiple Myeloma Cell Growth and Survival von Diedrich, Jonathan D, Cole, Craig E, Pianko, Matthew J, Colacino, Justin A, Bernard, Jamie J

Volltext

Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States von Auclair, Daniel, Mansfield, Carol, Fiala, Mark A, Chari, Ajai, Cole, Craig E, Kaufman, Jonathan L, Orloff, Gregory J, Siegel, David S, Zonder, Jeffrey A, Mange, Brennan, Yesil, Jennifer, Dalal, Mehul, Mikhael, Joseph R

Volltext

Antithrombin Supplementation in Adults with Acute Lymphoblastic Leukemia (ALL) Following Asparaginase Therapy: A Meta-Analysis von Mosalem, Osama, Mujer, Mark, Abu Rous, Fawzi, Cole, Craig E.

Volltext

Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven... von Bernal-Mizrachi, Leon, Nooka, Ajay K., Heffner, Leonard, Cole, Craig E., Vij, Ravi, Ye, J Christine, Hofmeister, Craig C, Rushton, John, Chen, Zhengjia, Goyal, Subir, Cinar, Munevver, Lonial, Sagar, Kaufman, Jonathan L.

Volltext

Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven... von Bernal-Mizrachi, Leon, Nooka, Ajay K., Heffner, Leonard, Cole, Craig E., Ye, Jing C., Vij, Ravi, Hofmeister, Craig C., Rushton, John, Chen, Zhengjia, Goyal, Subir, Switchenko, Jeffrey M., Lonial, Sagar, Kaufman, Jonathan L.

Volltext

Circulating endothelial cells in patients with chronic lymphocytic leukemia von Go, Ronald S., Jobe, Dean A., Asp, Krista E., Callister, Steven M., Mathiason, Michelle A., Meyer, Lori A., Bottner, Wayne A., Cole, Craig E., Farnen, John P., Frisby, Kathleen A.

Volltext

Financial Burden Is Associated with Postponing Care and Decreasing Physical and Emotional Quality of Life Among Patients with Multiple Myeloma and Chronic Lymphocytic Leukemia von Fortune, Erica E., Miller, Melissa F., Kranzler, Elissa C., Ackourey, Jemeille, Clark, Kelly, Badt, Heather, Bohannon, Linda, Cole, Craig E., Leblanc, Thomas W., Zaleta, Alexandra K

Volltext

Role of Aneuploidy in Transcriptional Regulation and Clinical Prognosis in Relapsed and/or Refractory Multiple Myeloma (RRMM) von Su, Christopher T, Chen, Liying, Chen, Jason, Parkin, Brian, Polk, Avery, Kandarpa, Malathi, Cole, Craig E., Campagnaro, Erica, Vo, Josh, Robinson, Dan, Wu, Yi-Mi, Talpaz, Moshe, Yesil, Jennifer, Auclair, Daniel, Bergsagel, P. Leif, Chinnaiyan, Arul, Baladandayuthapani, Veerabhadran, Ye, J Christine

Volltext

Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven... von Bernal-Mizrachi, Leon, Nooka, Ajay K, Heffner, Leonard, Cole, Craig E., Ye, J Christine, Vij, Ravi, Hofmeister, Craig C, Rushton, John, Chen, Zhengjia, Chang, Zhao, Cinar, Munevver, Auclair, Daniel, Lonial, Sagar, Kaufman, Jonathan L.

Volltext

Desiderosmia (Craving of Olfaction): A Novel Symptom Associated with Iron Deficiency Anemia von Hansen, Bryar, Ravindran, Aishwarya, Bottner, Wayne A., Cole, Craig E., Farnen, John P., Go, Ronald S.

Volltext

Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven... von Bernal-Mizrachi, Leon, Cole, Craig E., Heffner, Leonard, Nooka, Ajay K, Vij, Ravi, Kelkar, Nyaya, Sridhar, Akshata, Cinar, Munevver, Chen, Zhengjia, Chang, Zhao, Lonial, Sagar, Kaufman, Jonathan L

Volltext

Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Initial Data from a Phase 2, Non-Comparative Study von Jagannath, Sundar, Berdeja, Jesus G., Rifkin, Robert M, Cole, Craig E., Thompson, Michael Alan, Vij, Ravi, Popa-McKiver, Mihaela, Saleem, Rao, Sy, Oumar, Bensinger, William

Volltext